Cargando…
AGEs and RAGE: metabolic and molecular signatures of the glycation-inflammation axis in malignant or metastatic cancers
From attributing mutations to cancers with the advent of cutting-edge genetic technology in recent decades, to re-searching the age-old theory of intrinsic metabolic shift of cancers (Warburg’s glycolysis), the quest for a precise panacea for mainly the metastatic cancers, remains incessant. This re...
Autores principales: | Palanissami, Gowri, Paul, Solomon F.D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Open Exploration Publishing
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10645465/ https://www.ncbi.nlm.nih.gov/pubmed/37970208 http://dx.doi.org/10.37349/etat.2023.00170 |
Ejemplares similares
-
RAGE (Receptor for Advanced Glycation Endproducts), RAGE Ligands, and their role in Cancer and Inflammation
por: Sparvero, Louis J, et al.
Publicado: (2009) -
Cross-talks in colon cancer between RAGE/AGEs axis and inflammation/immunotherapy
por: Mollace, Annachiara, et al.
Publicado: (2021) -
Polymorphisms −374 T/A and −429 T/C of the Receptor for Advanced Glycation End-Products (RAGE) and Serum Levels of RAGE (sRAGE) Are Not Associated with Metabolic Syndrome
por: González-Guerrero, Diana Elizabeth, et al.
Publicado: (2023) -
Receptor for the Advanced Glycation End Products (RAGE) Pathway in Adipose Tissue Metabolism
por: Gutowska, Klaudia, et al.
Publicado: (2023) -
The AGE-RAGE Axis and the Pathophysiology of Multimorbidity in COPD
por: Reynaert, Niki L., et al.
Publicado: (2023)